Prevalence of Gastric Inlet Patches of the Cervical Esophagus.

NCT ID: NCT01056003

Last Updated: 2010-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

4000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-06-30

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As known from several observational and retrospective endoscopic studies the prevalence of gastric inlet patches (GIPs) of the cervical esophagus is estimated between 1-10%. In most cases GIPs are found within endoscopy as an incident finding, since in most cases they are harmless and do not cause any symptoms. None the less several data exist where an association between GIPs and globus sensations is discussed. Case reports even refer to bleeding complications and moreover to malignant transformations of GIPs.

As a result of the assumed association of GIPs and globus sensations we performed a pilot trial. Here we included 10 patients with globus and GIPs and were able to demonstrate a significant symptom relief after ablation of the GIP (Meining et al, Endoscopy 2006). To exclude a potential placebo-effect we concluded a multicenter and sham controlled trial where we imposingly were able to prove the symptom relief after ablation of the GIPs (Bajbouj et al, Gastroenterology 2009).

All patients, who are scheduled for esophagogastroduodenoscopy (EGD) in any of the above mentioned endoscopical departments are routinely standardized asked whether they have any hints suggestive for globus sensations (modified globus-questionnaire from Deary et al., J Psychosom Res 1995). Concurrently it is noted, whether the patients have endoscopical detected GIP. All GIPs are biopsied and examined in one institute. Together with anamnestic data (age, gender) a talley sheet gives a survey of all relevant information to prove or disprove following hypotheses.

Study hypotheses:

1. The presence of GIPs is associated with globus sensations. In other words: Do patients with globus sensations significantly more often have GIPs?
2. GIPs are not congenital, they arise in the course of the time and become symptomatic. In other words: Do GIPs significantly occur in more elderly people?
3. The more increased the GIPs diameter is the more likely globus sensations are present? In other words: Do huge GIPs cause significantly more often symptoms than small ones?
4. The more mucus-producing mucosa is histologically proven the more likely globus sensations are present? In other words: Do we find more cardiac mucosa in patients with symptoms than fundus mucosa?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Association of Heterotopic Gastric Mucosa of the Cervical Esophagus and Globus Sensations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

all patients admitting endoscopy for EGD

Endoscopy

Intervention Type OTHER

observational endoscopy in all patients an EGD is planned anyway

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endoscopy

observational endoscopy in all patients an EGD is planned anyway

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

* emergency EGD
* any condition which contraindicates biopsy sampling
* unavailable informed consent for the GD
Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut für Allgemeine Pathologie und Pathologische Anatomie der TU München

UNKNOWN

Sponsor Role collaborator

Klinik für Kinder und Jugendmedizin, Klinikum Dritter Orden; München

UNKNOWN

Sponsor Role collaborator

Klinik für Kinder und Jugendmedizin, Universitätsklinikum Ulm

UNKNOWN

Sponsor Role collaborator

Kinderklinik im Dr. von Haunerschen Kinderspital, Universität München

UNKNOWN

Sponsor Role collaborator

Technical University of Munich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Klinikum rechts der Isar, Technische Universitaet Munich

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Monther Bajbouj, MD

Role: PRINCIPAL_INVESTIGATOR

Technical University Munich

Sybille Koletzko, Professor

Role: PRINCIPAL_INVESTIGATOR

Kinderklinik im Dr. von Haunerschen Kinderspital, Universität München

Slim Saadi, MD

Role: PRINCIPAL_INVESTIGATOR

Klinik für Kinder und Jugendmedizin, Klinikum Dritter Orden; München

Susanne Liptay, MD

Role: PRINCIPAL_INVESTIGATOR

Technical University Munich

Carsten Posovsky

Role: PRINCIPAL_INVESTIGATOR

University Ulm

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinikum rechts der Isar

Munich, Bavaria, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Monther Bajbouj, MD

Role: CONTACT

+49-89-41400

Alexander Meining, Professor

Role: CONTACT

+49-89-41400

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Monther Bajbouj, MD

Role: primary

+49-89-41400

References

Explore related publications, articles, or registry entries linked to this study.

Bajbouj M, Becker V, Eckel F, Miehlke S, Pech O, Prinz C, Schmid RM, Meining A. Argon plasma coagulation of cervical heterotopic gastric mucosa as an alternative treatment for globus sensations. Gastroenterology. 2009 Aug;137(2):440-4. doi: 10.1053/j.gastro.2009.04.053. Epub 2009 May 4.

Reference Type RESULT
PMID: 19410576 (View on PubMed)

Meining A, Bajbouj M, Preeg M, Reichenberger J, Kassem AM, Huber W, Brockmeyer SJ, Hannig C, Hofler H, Prinz C, Schmid RM. Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trial. Endoscopy. 2006 Jun;38(6):566-70. doi: 10.1055/s-2006-925362.

Reference Type RESULT
PMID: 16802267 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Gips in Kids

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Thorcolumbar Kyphosis Patients With GERD
NCT04521985 NOT_YET_RECRUITING